Icecure MedicalICCM -15.10%46 PB Ratio is 1.88 as of Jun. 28, 2026, which is 44% below its 10-year median of 3.38. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.37 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Icecure Medical ranks better than 53.49% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-28), Icecure Medical's share price is $5.915. Icecure Medical's Book Value per Share for the quarter that ended in Mar. 2026 was $3.14. Hence, Icecure Medical's PB Ratio of today is 1.88.
The historical rank and industry rank for Icecure Medical's PB Ratio or its related term are showing as below:
ICCM'
s PB Ratio Range Over the Past 10 Years
Min: 0.76 Med: 3.38 Max: 23.17
Current: 1.88
During the past 13 years, Icecure Medical's highest PB Ratio was 23.17. The lowest was 0.76. And the median was 3.38.
ICCM's PB Ratio is ranked better than 53.49% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 1.99
vs ICCM: 1.88
During the past 12 months, Icecure Medical's average Book Value Per Share Growth Rate was 4.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -39.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -25.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Icecure Medical was 47.10% per year. The lowest was -45.50% per year. And the median was -23.30% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Icecure Medical PB Ratio Related Terms
Icecure Medical PB Ratio Historical Data
* Premium members only.
The historical data trend for Icecure Medical's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Icecure Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Icecure Medical PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Icecure Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Icecure Medical's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Icecure Medical (ICCM) has a PB Ratio of 1.88 as of Jun. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Icecure Medical and its competitors. This is 44% below median its historical median of 3.38. Over the past decade, Icecure Medical's PB Ratio has ranged from 0.76 to 23.17. According to the industry distribution chart, Icecure Medical ranks #366 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 46.5%.
Is Icecure Medical's PB Ratio too high?
Icecure Medical's current PB Ratio of 1.88 is 44% below median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 23.17. The Medical Devices & Instruments industry median PB Ratio is 1.99. Icecure Medical's value of 1.88 is 5.5% below this industry median. Based on the distribution chart, Icecure Medical ranks #366 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's PB Ratio compare to IRIX and ADGM?
According to the Medical Devices & Instruments industry distribution chart, Icecure Medical ranks #366 out of 787 companies for PB Ratio. This puts Icecure Medical in the upper half of its industry. The industry median PB Ratio is 1.99. Icecure Medical's value of 1.88 is 5.5% below this benchmark. Historically, Icecure Medical's own PB Ratio has ranged from 0.76 to 23.17 over the past decade. While the company's 10-year median is 3.38 vs. the industry median of 1.99, Icecure Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 1.99, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Icecure Medical's current PB Ratio of 1.88 is 5.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Icecure Medical and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Icecure Medical's current PB Ratio is 1.88, which is 44% below median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.37, compared to a current price of $5.92 — trading 72.3% below its estimated fair value. The current PB Ratio is 1.88, which is 44% below median its 10-year median of 3.38 and 5.5% below the Medical Devices & Instruments industry median of 1.99. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Icecure Medical (ICCM), the current PB Ratio is 1.88 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icecure Medical (ICCM) Overvalued in 2026?
Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued.
The current stock price of $5.92 is trading 72.3% below its estimated GF Value™ of $21.37.
GuruFocus considers Icecure Medical to be Possible Value Trap.
Key valuation signals for ICCM:
PB Ratio: 1.88 (44% below median its 10-year median of 3.38)
GF Value™: $21.37 vs. price of $5.92 (72.3% below fair value)
Industry Position: 5.5% below the Medical Devices & Instruments median (#366 of 787)
No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score
Get the complete analysis for ICCM
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICCM has been successfully added to your 
